Anjali Owens is a Cardiology physician affiliated with Hospital of the University of Pennsylvania. OpenAlex indexes 362 publications with 10,968 citations (h-index 43).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Spruce Street
Philadelphia, PA 19104
Telephone
215-314-0343Registry record last updated 13 Sept 2017.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20259 payments$11,913openpaymentsdata.cms.gov ↗
- Alexion Pharmaceuticals, Inc.Program year20254 payments
- BridgeBio Pharma, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
71.6%Loop diuretic24.1%Furosemide100%Part D≥17 patientsAldosterone antagonist (MRA)22.2%Spironolactone100%Part D≥20 patients+ 2 more classes in this area
Blood & clotting
20.4%Factor Xa inhibitor20.4%Eliquis100%Part D<11 patientsMetabolism & gastrointestinal
8%SGLT2 inhibitor8%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
New England Journal of Medicine
2025 - Demographic-Based Personalized Left Ventricular Hypertrophy Thresholds for Hypertrophic Cardiomyopathy Diagnosis
Journal of the American College of Cardiology
2025 - Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
New England Journal of Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Mohamed Gad, MD, MPH
Hospital of the University of Pennsylvania
Lawrence Wechsler, MD
Hospital of the University of Pennsylvania
John Hirshfeld, MD
Hospital of the University of Pennsylvania
Noelle Frey, MD
Hospital of the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”